Sign In
Buy MRK
$120.78
+1.69 (+1.41%)
At Close: Jun 11, 2026
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that KEYTRUDA® (pembrolizumab), in combination with paclitaxel, with or
Merck & Co., Inc. $MRK Shares Purchased by Compagnie Lombard Odier SCmA
05:06am, Thursday, 02'nd Apr 2026
Compagnie Lombard Odier SCmA boosted its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 19.5% during the undefined quarter, according to its most recent 13F filing with the SEC. The fund own
Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30
07:00am, Wednesday, 01'st Apr 2026
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30.
Econ Financial Services Corp Sells 8,757 Shares of Merck & Co., Inc. $MRK
04:41am, Wednesday, 01'st Apr 2026
Econ Financial Services Corp lowered its stake in Merck and Co., Inc. (NYSE: MRK) by 36.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and
April Dogs Of The Dow: One To Buy
12:04pm, Tuesday, 31'st Mar 2026
Verizon (VZ) is the only Dow stock in April 2026 meeting the ideal of annual dividends from $1K invested exceeding its share price, supported by robust free cash flow. Analyst forecasts suggest the to
Barclays names top 4 defensive stocks to weather global uncertainty
09:56am, Tuesday, 31'st Mar 2026
As Dow Jones slides into the “correction territory” and the benchmark S&P 500 index logs its fifth consecutive week of losses, investors are increasingly desperate for a port in the storm. Accordi
Infinimmune, Merck enter into antibody discovery pact
09:13am, Tuesday, 31'st Mar 2026
Biotech firm Infinimmune said on Tuesday it has entered into a deal with Merck , that could be worth up to about $838 million in milestone payments, to discover and develop multiple antibodies �
Infinimmune Enters Collaboration with Merck to Discover Novel Human Antibody Therapeutics
08:00am, Tuesday, 31'st Mar 2026
ALAMEDA, Calif.--(BUSINESS WIRE)-- #AI--Infinimmune Enters Collaboration with Merck to Discover Novel Human Antibody Therapeutics.
Financial Planning Hawaii Inc. Makes New $679,000 Investment in Merck & Co., Inc. $MRK
05:10am, Tuesday, 31'st Mar 2026
Financial Planning Hawaii Inc. bought a new stake in shares of Merck and Co., Inc. (NYSE: MRK) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exc
Boston Common Asset Management LLC Grows Stock Holdings in Merck & Co., Inc. $MRK
04:34am, Tuesday, 31'st Mar 2026
Boston Common Asset Management LLC lifted its holdings in Merck and Co., Inc. (NYSE: MRK) by 3.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Co
Merck's drug reduced bad cholesterol by 64.6% in late-stage trial
11:54am, Monday, 30'th Mar 2026
Merck's oral drug reduced bad cholesterol by 64.6% in a late-stage trial, it said on Monday, as the company looks for its next blockbuster candidate.
How Merck's New Cholesterol Buster Will 'Move The Needle' 'By Removing The Needle'
11:45am, Monday, 30'th Mar 2026
Merck's experimental cholesterol buster easily outperformed a triplet of medications, the Dow Jones component said Monday.
RAHWAY, N.J.--(BUSINESS WIRE)--Enlicitide, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions Compared to Oral Non-Statin Therapies.
Cypress Wealth Services LLC Purchases 9,854 Shares of Merck & Co., Inc. $MRK
05:04am, Sunday, 29'th Mar 2026
Cypress Wealth Services LLC increased its position in shares of Merck and Co., Inc. (NYSE: MRK) by 256.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchang
Chesley Taft & Associates LLC Has $6.37 Million Holdings in Merck & Co., Inc. $MRK
05:04am, Sunday, 29'th Mar 2026
Chesley Taft and Associates LLC lifted its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 9.4% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exc
